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Introduction. Several studies show that hypoglycemia causes QT interval prolongation. The aim of this study was to investigate
the effect of QT measurement methodology, heart rate correction, and insulin types during hypoglycemia. Methods. Ten adult
subjects with type 1 diabetes had hypoglycemia induced by intravenous injection of two insulin types in a cross-over design. QT
measurements were done using the slope-intersect (SI) and manual annotation (MA) methods. Heart rate correction was done
using Bazett’s (QTcB) and Fridericia’s (QTcF) formulas. Results. The SI method showed significant prolongation at hypoglycemia
for QTcB (42(6) ms; P < .001) and QTcF (35(6) ms; P < .001). The MA method showed prolongation at hypoglycemia for QTcB
(7(2) ms, P < .05) but not QTcF. No difference in ECG variables between the types of insulin was observed. Discussion. The method
for measuring the QT interval has a significant impact on the prolongation of QT during hypoglycemia. Heart rate correction may
also influence the QT during hypoglycemia while the type of insulin is insignificant. Prolongation of QTc in this study did not
reach pathologic values suggesting that QTc prolongation cannot fully explain the dead-in-bed syndrome.
1. Introduction
The introduction of human insulin in the 1990s led to an
increase in the number of sudden nocturnal deaths of young
people with type I diabetes. This specific type of death in
diabetes was termed the “dead in bed” syndrome and it was
hypothesized that the deaths were caused by hypoglycemia
[1]. The pathophysiological mechanisms behind the deaths
are still not understood although circumstantial evidence
suggests that they are cases of fatal cardiac arrhythmia.
The proposed proarrhythmic effect of hypoglycemia is
thought to be mediated by sympathoadrenal activation and
hypokalaemia [2].
It has been reported that insulin-induced hypoglycemia
affects repolarization of the cardiac cells in both healthy
subjects [3, 4] and people with diabetes [5–7]. The altered
repolarization is notable on the electrocardiogram (ECG) as
a flattened T wave [4, 6] and a prolonged heart rate-corrected
QT interval (QTc) [3, 5]. A prolonged QTc is associated with
an increased risk of sudden cardiac death [8, 9], and QTc
has thus been the primary variable investigated in studies of
the proarrhythmic effect of hypoglycemia. The degree of QTc
prolongation during clamped hypoglycemia ranges from
5 ms [6] to 60 ms [3] with one study reporting a prolongation
of 156 ms [5]. Thus, in some studies the prolongation of
QTc is seen to be insignificant while other studies show
a significant and potentially dangerous prolongation. We
hypothesize that differences in methodology when measur-
ing the QT interval and heart rate correcting the QT interval
may partly explain the discrepancies between the reported
prolongations of QTc. It is known that Bazett’s formula
for heart rate correction is associated with both over- and
undercorrection of QTc at heart rates outside a narrow
range [10]. Nevertheless, Bazett’s formula is still the most
often used heart rate correction, when investigating QTc
during hypoglycemia. The methodology when measuring the
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Figure 1: Schematic design of the study. Measurements of ECG
(•) are taken three times in a baseline interval prior to insulin
injection (t–30, t–10, and t0), 15 minutes after insulin injection (t15),
at blood glucose nadir (thypo), and 90 minutes after blood glucose
nadir (tpost).
T wave offset also has an impact on the QT interval as for
example the often used tangent method is more sensitive to
the flattening of the T wave seen during hypoglycemia [11].
In addition, modern insulin analogues may have a different
effect on the QTc than human insulin, although this has
previously been shown not to be the case [12].
The “dead in bed” syndrome and the potential prolon-
gation of QTc during hypoglycemia are still of concern to
many patients and physicians. If these tragic deaths are to
be avoided, an increased understanding of the phenomenon
is necessary. It has been suggested that if patients with
an increased risk of prolonged QT during hypoglycemia
could be identified, a selective beta blocker might have a
therapeutic role [2]. However, before considering preventive
treatment, it is important to clarify if hypoglycemia indeed
causes significant prolongation of QTc and identify the fac-
tors in study methodology that may cause the discrepancies
among the reported results in the literature. Thus, in the
present study, we investigate the potential bias associated
with measurement technique, heart rate correction, and type
of insulin when measuring the QTc during hypoglycemia.
2. Methods
2.1. Subjects. The study population consisted of 10 subjects
(6 men, 4 women; age: 32 ± 9 years) with type 1 diabetes
(C-peptide negative). Subjects had HbA1c <10%, duration of
diabetes of 15 ± 10 years, and none had signs of neuropathy.
Each subject was studied on two weekends separated by at
least 1 month. At each weekend hypoglycemia was induced
two times: saturday at 2 AM and 10 PM. Subjects were
randomized to use either insulin aspart (Iasp) (NovoRapid,
Novo Nordisk A/S, Denmark) or human insulin (HI)
(Actrapid, Novo Nordisk A/S, Denmark) the first weekend
in a cross-over design so the other type of insulin was used
at the next weekend. Written informed consent was obtained
from all subjects, and the study protocol was approved by the
Regional Ethics Committee.
2.2. Procedures. A catheter (Venflon, Viggo AB, Sweden) was
inserted into an antecubital arm vein for administration
of insulin and glucose. Hypoglycemia was induced by
a single bolus of insulin (0.1 U/kg bodyweight) injected
directly into the blood. Blood glucose was measured by a
HemoCue Analyzer (HemoCue AB, Angelholm, Sweden).
Measurements of blood glucose were taken 30 minutes prior
to insulin injection and at least every 5 minutes following
the injection. When blood glucose <2.5 mmol/L was reached,
intravenous glucose (10%) was administered to restore the
blood glucose.
2.3. ECG Measurements. ECG was recorded from lead II by
disposable Ag/AgCl electrodes (Blue Sensor L, Ambu A/S,
Denmark). ECG was sampled by a data acquisition system
(Portilab 16 + 2, Twente Medical Systems International,
Holland) at 400 Hz with 12-bit resolution.
Epochs of 60 seconds of ECG were analyzed 30 minutes
prior to insulin injection (t−30), 10 minutes prior to insulin
injection (t−10), at insulin injection (t0), 15 minutes after
insulin injection (t15), at blood glucose nadir (thypo), and
90 minutes after blood glucose nadir (tpost) (Figure 1).
QT intervals were measured from each epoch using both
a manual annotation (MA) and a semi-automatic “slope
intersect” (SI) method.
MA measurements were carried out by independent QT
experts (Spacelabs Healthcare, Washington, USA) blinded
to the study design and all other information except the
ECG. Each epoch was manually reviewed for artifacts
and a representative beat was obtained. Distortion of the
representative beat was minimized by selecting areas of the
epoch with minimal artifacts to include in representative beat
generation. From the representative beat QT intervals were
measured from the first high-frequency deflection of the QRS
complex to the offset of the T wave. Average RR interval of
the QRS complexes selected for the representative beat was
used to provide heart rate correction. In addition, the R peak
and T peak amplitudes relative to the isoelectric line were
measured. All measurements were done manually using an
electronic caliper and reviewed by a cardiologist.
SI measurements were carried out using custom anal-
ysis software developed in MatLab (Version 7.8.0.347, The
Mathworks, Inc., Natick, MA, USA). Templates representing
the average PQRST complex in epochs were generated using
manually selected areas with minimal artifacts. The end of
the T wave in each template was determined automatically
using the “slope intersect” method [13]. In addition, the R
peak and T peak amplitudes relative to the isoelectric line
were also measured. All templates and associated fiducial
points were manually reviewed on-screen in random order
by an observer blinded to the corresponding blood glucose
and the subjects’ clinical data. Templates were rejected if arti-
facts precluded reliable measurements but no adjustments
to the QT interval were made to reduce the subjectivity of
the measurements. The median RR interval in each segment
was used to heart rate correcting the QT interval. In both
MA and SI methods QT intervals were corrected by Bazett’s
formula (QTcB) [14] and Fridericia’s formula (QTcF) [15].
As a measure of the T wave flatness the T peak to R peak
amplitudes ratio (T/R Ratio) was calculated.
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Figure 2: Measurements of the T wave offset from ECG lead II
using the semiautomatic slope-intersect method (SI) and manual
annotation (MA) method. The two ECGs are from t0 (left side)
and at thypo (right side) at the same episode. At t0 the SI method
underestimates the end of the T wave compared with the MA
method. With the flattening of the T wave at thypo the SI method
overestimates the end of the T wave compared with the MA method.
2.4. Data Analysis. Measurements at t−30, t−10 and t0 were
averaged and collectively called tbaseline to reduce the amount
of statistical analyses. A linear mixed effects model was used
to analyze the changes in ECG variables. Time (levels: tbaseline,
t15, thypo, and tpost) and treatment (levels: Iasp, HI) were
included as fixed effects in the model together with a time-
treatment interaction term. Subjects were included in the
model as a random effect on the intercept. Weekend was
included as a random effect within subjects and episodes as
a random effect within weekends. Separate models for each
ECG variable were fitted using restricted maximum likeli-
hood. An analysis of variance of the fitted model was used
to test for significant changes in variables. With variables
showing statistical significance, Dunnett’s posthoc tests were
used to test for significant differences between different factor
levels. P values <.05 were considered significant. Results from
the statistical model are reported as mean (SE), all other
results are reported as mean ± SD. Statistical analyses were
performed in R version 2.9.1.
3. Results
Seven (17.5%) of the recorded episodes of hypoglycemia
were excluded because the subject had a blood glucose
≤3.5 mmol/L at t−30 (n = 6) or because of instrumentation
issues (n = 1). Thus a total of 33 episodes were used in the
data analysis with a minimum of two episodes available from
each subject. Hypoglycemia was reached 45 ± 32 minutes
after insulin was administered with blood glucose at nadir of
2.4 ± 0.3 mmol/L. The measured variables summarized for
each time point are shown in Table 1.
Using the MA method significant prolongation of QTcB
from tbaseline to thypo was observed (ΔQTcB: 7(2); P < .05)
but no prolongation of QTcF was seen (ΔQTcF: 1(2); P >
.05). With the SI method both QTcB and QTcF prolonged
significantly (ΔQTcB: 42(6); P < .001, ΔQTcF: 35(6);
P < .001) (Table 2). Heart rate and T/R ratio decreased
significantly with both the MA and SI methods (P < .001).
The changes in variables from tbaseline to t15 were similar to
the change from tbaseline to thypo (Table 2). At tpost, QTcB and
QTcF had returned to tbaseline levels while RR interval and
T/R ratio remained decreased for both MA and SI methods
(Table 2).
There was a significant difference between ΔQTcF mea-
sured by the SI and MA methods (34 ms; P < .001) (Table 3,
Figure 3). The difference between ΔQTcB and ΔQTcF was
also significant (8 ms; P < .001) (Table 3, Figure 4). No
significant difference between HI and Iasp was found on any
of the measured ECG variables.
4. Discussion
The MA method showed modest increase in QTcB and
no increase in QTcF during hypoglycemia, while the SI
method showed considerable prolongation of both QTcB
and QTcF. Comparing the two methods directly showed
that SI underestimated the QT interval at baseline and
overestimated it at hypoglycemia compared to MA.
The use of the SI method for measuring the end of
the T wave is known to be sensitive to changes in T wave
amplitude, although the method was originally meant for
cases with partial T-U fusion [11, 16]. In particular a
flattened T wave will cause an overestimation of the QT
interval with the SI method when compared to the MA
method (Figure 2). Since there exists no gold standard of
measuring the QT interval, neither of the measurement
techniques can from this study be judged more correctly
than the other. However, the discrepancy between the two
methods illustrates that comparing studies of hypoglycemia
using different QT measurement methods may be prob-
lematic. Also, it is apparent from the results that the SI
method produces significantly longer QT intervals than the
MA method which could indicate a higher probability of
false positives with the SI method. An approach which
could eliminate the bias associated with measuring the QT
interval is to use alternative T wave morphology variables.
Xue and Reddy [17] used principal component analysis of
the T wave and showed that this approach had superior
reproducibility than several QT measurement methods.
Alternative T wave morphology parameters might therefore
be better at characterizing changes in repolarization during
hypoglycemia.
A pathologically prolonged QTc interval is usually
defined as >450 ms for men and >470 ms for women [18].
In the present study, mean QTc did not exceed these
thresholds with any of the methods. This could indicate
that prolongation of the QTc cannot in itself explain the
mechanism implicated in the dead-in-bed syndrome.
The differences between QTcB and QTcF in this study
were larger at hypoglycemia than at baseline. It is known that
Bazett’s formula tends to overcorrect the QTc at higher heart
rates [10]. In this study we observed a significant increase in
heart rate during hypoglycemia which may have contributed
to an overcorrection by Bazett’s formula compared to
Fridericia’s formula. Similar findings of differing results
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Table 1: Blood glucose and ECG variables at baseline (tbase), at blood glucose nadir (thypo) and 90 minutes after blood glucose nadir (tpost).
Results are mean ± SD [range].
Time
Method Variable tbase thypo tpost
Blood Glucose 10.4 ± 3.8 [5.0–19.5] 2.4 ± 0.3 [1.7–2.9] 10.1 ± 3.3 [5.7–18.7]
MA
RR (ms) 933 ± 157 [665–1278] 845 ± 128 [640–1125] 871 ± 159 [665–1245]
QTcF (ms) 412 ± 19 [379–463] 412 ± 21 [374–460] 413 ± 22 [378–453]
QTcB (ms) 418 ± 24 [384–472] 425 ± 23 [391–475] 424 ± 26 [375–473]
T/R Ratio (−) 0.3 ± 0.14 [0.1–0.62] 0.2 ± 0.1 [0.03–0.44] 0.23 ± 0.11 [0.07–0.51]
SI
RR (ms) 935 ± 160 [658–1272] 836 ± 139 [625–1132] 869 ± 161 [637–1249]
QTcF (ms) 399 ± 27 [363–452] 433 ± 61 [368–501] 408 ± 35 [359–496]
QTcB (ms) 405 ± 32 [364–467] 447 ± 66 [379–517] 419 ± 40 [364–506]
T/R Ratio (−) 0.31 ± 0.13 [0.12–0.66] 0.2 ± 0.1 [0.07–0.47] 0.24 ± 0.1 [0.12–0.47]
Table 2: Estimated changes in ECG variables over time with tbase as reference point. Estimates are based on a statistical model fit to each
variable.
Time
t15 thypo tpost
Method Variable β (SE) 95% CI β (SE) 95% CI β (SE) 95% CI
MA
RR (ms) −55 (16)†[−92;-18] −87(14)‡ [−121;−53] −64(15)‡[−99;−29]
QTcF (ms) 5 (2) [−1;10] 1(2) [−4;5] 1(2) [−4;6]
QTcB (ms) 9 (3)†[3;15] 7(2)† [2;13] 6(2)†[1;12]
T/R Ratio (−) −0.07 (0.01)‡[−0.1;−0.05] −0.1(0.01)‡ [−0.12;−0.08] −0.06 (0.01)‡ [−0.08;−0.04]
SI
RR (ms) −60 (16)‡[−97; −23] −98(14)‡ [−132;−64] −69(15)‡[−105; −34]
QTcF (ms) 30 (6)‡[15;44] 35(6)‡ [22;48] 8(6) [−5;22]
QTcB (ms) 34 (7)‡[19;50] 42(6)‡ [28;56] 13(6) [−1;28]
T/R Ratio (−) −0.08 (0.01)‡[−0.1; −0.06] −0.1(0.01)‡[−0.12; −0.08] −0.06 (0.01)‡[−0.08; −0.04]
Significances (compared with tbaseline): †P < .05, ‡P < .001.
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Figure 3: The difference over the course of a hypoglycemia episode
in QTc corrected by Fridericia’s formula (QTcF) for the manual
annotation (MA) and slope-intersect (SI) methods. Data is mean
± SE estimated from the statistical model.
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Figure 4: Difference between QTc corrected by Bazett’s (QTcB) and
Fridericia’s (QTcF) formulas. The QT interval is measured using the
manual annotation (MA) method. Data is mean ± SE estimated
from the statistical model.
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Table 3: Differences at tbase and thypo between the two methods for QT measurement (semi-automatic slope-intersect (SI) and manual
annotation (MA)) and heart rate correction (Bazett’s (QTcB) and Fridericia’s (QTcF)).
tbase thypo t-test (thypo − tbase)
Difference Method Mean ± SD Mean ± SD Mean 95% CI P-value
QTcB-QTcF
MA 6 ± 11 13 ± 10 7 [5;8] <.001
SI 6 ± 11 13 ± 11 8 [5;10] <.001
SI – MA
QTcB −13 ± 12 22 ± 51 35 [20;51] <.001
QTcF −13 ± 12 21 ± 50 34 [19;49] <.001
using the two correction formulas have been reported [6]
although they in other cases produce similar results [19].
One of the main limitations of the study is the absence
of a control group. Without a control group it is less clear if
the observed QT prolongation is caused by hypoglycemia per
se. Indeed, insulin could act as a confounding variable as it
has been shown to cause moderate QT interval prolongation
[20]. To account for the effect of insulin, we measured the
ECG variables of interest 15 minutes after insulin injection
where the subjects were still normoglycemic. We anticipated
that this measurement would quantify the effect of hyperin-
sulinemia alone. The results show that the change in ECG
variables 15 minutes after insulin injection is comparable
to the change at hypoglycemia. This could indicate that the
observed changes during hypoglycemia may not be caused
by hypoglycemia per se but rather by hyperinsulinaemia.
We acknowledge that the small number of subjects in the
study limits its generalisability to the general population,
although measurements on each subject were repeated to
reduce intrasubject variation. Additionally, the use of only
one ECG lead for QT measurement may have introduced
some variation in the measurements, which could have been
mitigated by the use of several leads.
The results of this study are in agreement with previous
studies of experimentally induced hypoglycemia using the
MA method [4, 6] although some studies also report a QTc
prolongation [5, 11]. Studies using the SI method consis-
tently find significantly prolonged QTc during hypoglycemia
[2, 3, 12, 19, 21]. We found no difference in the observed
variables between HI and Iasp which is in line with previous
findings [12]. Ireland and colleagues [11] compared the SI
and MA methods and concluded that the SI method was
preferred over the MA method because of a lower inter
observer difference despite an overestimation of the QT
interval at hypoglycemia. We cannot infer on inter-observer
differences from our study but our results confirm that the SI
method overestimates the QT interval during hypoglycemia.
5. Conclusion
Conclusively, our results suggest that the methodology used
for measuring and heart rate correcting the QT interval
during hypoglycemia may have a significant impact on the
measured prolongation of QTc. The SI method overesti-
mates the QT interval compared to the MA method at
hypoglycemia while Bazett’s formula overcorrects the QTc
compared to Fridericia’s formula. The type of insulin for
inducing hypoglycemia does not influence QT prolongation.
Prolongation of QTc in this study did not reach pathologic
values which suggest that additional factors play a role in the
pathogenesis of the dead-in-bed syndrome.
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